GMC Guideline for MASLD 2026
The Global NASH/MASH Council (GNC) has published its 2026 Updated Global Consensus Recommendations for MASLD/MASH in Clinical Gastroenterology and Hepatology. Developed through a structured Delphi process involving 40 international experts, these recommendations provide a practical, evidence-based framework for identifying high-risk patients, assessing liver fibrosis using noninvasive tests (FIB-4, VCTE, and ELF), initiating newly approved therapies...Continue reading→
Oman’s Remarkable Commitment to Medical Research and Innovation
Heartfelt congratulations to University Medical City (UMC) in Muscat, Oman, on its outstanding Second Annual Research Day, held under the inspiring theme “From Evidence to Excellence.” This exceptional scientific gathering brought together more than 600 researchers, academic leaders, clinicians, and distinguished government officials, including ministers, reflecting Oman’s remarkable commitment to advancing medical research, scientific innovation,...Continue reading→
Beyond BMI: A Global Study from the Global NASH/MASH Council Redefines Risk in Lean MASLD
A new study, now published in JAMA, comes from the Global MASLD (G-MASLD) project, launched in 2023 by the Global NASH/MASH Council (GNC). Led by Dr. Zobair Younossi, the project brought together more than 60 investigators from 41 countries across Asia, Europe, the Middle East and North Africa, Latin America, and North America. The result...Continue reading→
GNC/GLC Meeting at ALEH 2026 — Mexico City
The Global NASH/MASH Council (GNC) and Global Liver Council (GLC) meeting, held in conjunction with ALEH 2026 in Mexico City, Mexico, brought together leading hepatology experts from Latin America and the global GNC/GLC network. The session was moderated by Professors Mário Pessoa, Marco Arrese, and Zobair Younossi and opened with an update by Dr. Younossi...Continue reading→
Transforming the Future of Hepatology
Pleased to share our new publication, “Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma” in Liver International, summarizing key advances presented at the First Annual Paris International Liver Meeting (PILM) 2026. The review highlights a fundamental shift in hepatology—from managing advanced disease and its complications toward earlier identification,...Continue reading→
The dynamic spectrum of steatotic liver disease: the global perspective liver disease: the global perspective
One Spectrum, Not Three Silos: Rethinking Steatotic Liver Disease New review from the Global NASH/MASH Council (GNC) published in Nature Reviews Gastroenterology & Hepatology We are pleased to announce the publication of "The dynamic spectrum of steatotic liver disease: the global perspective" in Nature Reviews Gastroenterology & Hepatology. Led by Dr. Zobair M. Younossi and...Continue reading→
GNC and GLC Present 21 Abstracts at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2026
The Global NASH/MASH Council (GNC) and the Global Liver Council (GLC) are pleased to announce that 21 abstracts from our collaborative research programs have been accepted for presentation at The Liver Meeting 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), taking place this November in Denver, Colorado. The...Continue reading→
The Global NASH/MASH Council and Global Liver Council Meeting at EASL 2026, Barcelona, Spain
The biannual meeting of the Global NASH/MASH Council (GNC) and the Global Liver Council (GLC), held in conjunction with EASL 2026 in Barcelona, Spain, convened over 60 leading hepatology experts from across the globe. The meeting was opened by Professor Zobair Younossi, Chair of the GNC/GLC, and was followed by a scientific program featuring distinguished...Continue reading→
Paris International Liver Meeting 2027 – Save the Date
Dear Colleagues, We are pleased to invite you to save the date for the Paris International Liver Meeting 2027, taking place January 21–23, 2027, at Maison de la Chimie in Paris, France. Building on the outstanding success of PILM 2026, which attracted 722 participants from 67 countries, we are excited to bring together the international...Continue reading→
Research from Global NASH/MASH Council as Cover Story of Lancet Gastroenterology & Hepatology: Hidden Impact of Alcohol Underreporting on Disease Burden in the US
Research by the Global NASH/MASH Council (GNC), led by Zobair M. Younossi, MD, has been published as the Cover Story of The Lancet Gastroenterology & Hepatology. Using National Health and Nutrition Examination Survey (NHANES) data spanning 1988–2023, the study demonstrates that alcohol consumption is underreported in population surveys, resulting in underestimation of alcohol-related liver disease...Continue reading→